GP130-IN-1
GP130-IN-1 (compound 49) is a potent GP130 inhibitor with significant in vitro antitumor activity and higher selectivity than Bazedoxifene. GP130-IN-1 induces ultrastructural changes in cells, causing cell cycle arrest in the G0/G1 phase in a time-dependent manner and triggering apoptosis and autophagy. GP130-IN-1 can be used in the study of triple-negative breast cancer[1].
Product Specifications
CAS Number
2955243-69-1
UNSPSC
12352005
Target
Apoptosis; Autophagy; Interleukin Related
Type
Reference compound
Related Pathways
Apoptosis; Autophagy; Immunology/Inflammation
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/gp130-in-1.html
Smiles
O=C(N1C(C2=CC=C(O)C=C2)=CC3=C1C=CC(O)=C3)C4=C(F)C(F)=C(F)C(F)=C4F
Molecular Formula
C21H10F5NO3
Molecular Weight
419.30
References & Citations
[1]Wu P, et al. Structurally diverse design and synthesis of novel 2-phenylindole amide derivatives with anti-canine breast cancer activity[J]. Bioorganic Chemistry, 2024: 107788.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC683129-100 1x 100 µL
Cytokeratin 20 (KRT20) (Colorectal Epithelial Marker) (KRT20/3129R), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 